Literature DB >> 27499582

Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population.

Akira Andoh1, Atsushi Nishida1, Kenichiro Takahashi1, Osamu Inatomi1, Hirotsugu Imaeda1, Shigeki Bamba1, Katsuyuki Kito1, Mitsushige Sugimoto1, Toshio Kobayashi2.   

Abstract

Altered gut microbial ecology contributes to the development of metabolic diseases including obesity. In this study, we performed 16S rRNA sequence analysis of the gut microbiota profiles of obese and lean Japanese populations. The V3-V4 hypervariable regions of 16S rRNA of fecal samples from 10 obese and 10 lean volunteers were sequenced using the Illumina MiSeq(TM)II system. The average body mass index of the obese and lean group were 38.1 and 16.6 kg/m(2), respectively (p<0.01). The Shannon diversity index was significantly higher in the lean group than in the obese group (p<0.01). The phyla Firmicutes and Fusobacteria were significantly more abundant in obese people than in lean people. The abundance of the phylum Bacteroidetes and the Bacteroidetes/Firmicutes ratio were not different between the obese and lean groups. The genera Alistipes, Anaerococcus, Corpococcus, Fusobacterium and Parvimonas increased significantly in obese people, and the genera Bacteroides, Desulfovibrio, Faecalibacterium, Lachnoanaerobaculum and Olsenella increased significantly in lean people. Bacteria species possessing anti-inflammatory properties, such as Faecalibacterium prausnitzii, increased significantly in lean people, but bacteria species possessing pro-inflammatory properties increased in obese people. Obesity-associated gut microbiota in the Japanese population was different from that in Western people.

Entities:  

Keywords:  16S sequence; Bacteroides; Firmicutes; SCFA; datamining

Year:  2016        PMID: 27499582      PMCID: PMC4933688          DOI: 10.3164/jcbn.15-152

Source DB:  PubMed          Journal:  J Clin Biochem Nutr        ISSN: 0912-0009            Impact factor:   3.114


Introduction

Obesity is one of the most serious public health concerns worldwide.( More than 500 million people are obese, and its prevalence is dramatically increasing not only in developed countries but also in developing countries.( Obesity is associated with a higher risk for health problems such as heart disease, stroke, high blood pressure, diabetes mellitus and more.( A worldwide study in 2010 reported that obesity is associated with 3–4 million deaths, 4% of years of life lost, and 4% of disability-adjusted life-years lost.( The effect of the gut microbiota on human health is recognized as a mutually beneficial interaction between human and indigenous microorganisms that contributes to normal physiology and immune homeostasis.( The gut microbiota regulates metabolic function and energy balance, and an altered microbial ecology contributes to the development of several metabolic diseases including obesity. For example, the gut microbiota profile of obese people is characterized by a reduced proportion of the phylum Bacteroidetes and an increased proportion of the phylum Firmicutes, compared to lean people.( These changes are considered to affect the metabolic potential of the gut microbiota and enhance the body’s capacity to harvest energy from the diet.( Transfer of the gut microbiota from obese mice leads to a significantly greater accumulation of adipose tissue in recipient mice than a transfer of the gut microbiota from lean donors.( Thus, the gut microbiota is a critical environmental factor contributing to the development of obesity. In previous studies, alteration of the gut microbiota in obese people has been studied mainly in Western countries.( De Filippo et al.( previously demonstrated a difference in the gut microbial structure between obese European children and lean African children, indicating that environmental factors such as diet, sanitation and hygiene are important for shaping the gut microbiota. This leads to the possibility that obesity-associated gut microbiota might be different between Western and Asian populations, since lifestyles including dietary habits are quite different. However, alteration of the gut microbiota profile has not been extensively investigated in Asian people in general or in the Japanese population in particular. Therefore, it is important to investigate the obesity-associated gut microbiota profile of Japanese people. In the present study, we performed 16S rRNA sequence analysis of the gut microbiota profile in 10 obese and 10 lean Japanese people. Furthermore, bacterial species that contributed to the difference in the gut microbiota composition between obese and lean people were characterized.

Materials and Methods

Subjects and setting

Twenty volunteers (10 obese people and 10 lean people) were enrolled in this study. The body mass index (BMI) of the obese people was 38.1 ± 3.5 kg/m2 (mean ± SD) (range 35.7–49.2 kg/m2) and the BMI of the lean people was 16.6 ± 1.0 kg/m2 (range 14.2–17.7 kg/m2) (Table 1). No one was receiving medical treatment, drugs or supplements that could potentially modulate the gut microbiota. The Institutional Review Board of the Shiga University of Medical Science approved the study, and written informed consent was obtained from each person prior to enrolment.
Table 1

Backgrounds of volunteers enrolled in this study

ObeseLeanp value
Gender (female/male)5/55/5
Age [mean (range)]41 (35–55)45 (31–58)
Body weight (kg, mean ± SD)101.1 ± 13.642.5 ± 4.1<0.01
Height (cm, mean ± SD)162.9 ± 9.0159.8 ± 6.10.22
Body mass index (mean ± SD)38.1 ± 3.516.6 ± 1.0<0.01
Fasting blood sugar (mg/dl)107.0 ± 34.785.8 ± 7.1<0.05
Total chelesterol (mg/dl)222.2 ± 26.6216.6 ± 33.40.56
triglyceride (mg/dl)136.5 ± 53.865.1 ± 35.7<0.01

DNA extraction

DNA was extracted from fecal samples according to a previously described method.( The fecal samples were suspended in a buffer containing 4 M guanidium thiocyanate, 100 mM Tris-HCl (pH 9.0) and 40 mM EDTA and beaten in the presence of zirconia beads using the FastPrep FP100A Instrument (MP Biomedicals, Irvine, CA). Thereafter, the DNA was extracted from the beads-treated suspension using a Magtration System 12GC and GC series Magtration–MagaZorb DNA Common Kit 200 N (Precision System Science, Chiba, Japan). The final concentration of DNA sample was adjusted to 10 ng/µl.

16S rRNA sequencing

16S rRNA sequencing using the MiSeqTMII system (Illumina, San Diego, CA) was performed according to a previously described method.( The V3–V4 hypervariable regions of 16S rRNA were PCR amplified from microbial genomic DNA using the following universal primers: 341F, 5'-AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTCCTACGGGAGGCAGCAGCCTACGGGAGGCAGCAG-3';( 806R, 5'-CAAGCAGAAGACGGCATAGAGATNNNNNNGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGGACTACHVGGGTWTCTAAT-3'.( PCR products were purified through a MultiScreen PCR filter plate (Merck Millipore, Darmstadt, Germany). Barcoded V3 and V4 amplicons were sequenced using the paired-end, 2 × 250-bp cycle run on the MiSeqTMII system with MiSeq Reagent Kit ver. 2 (500 Cycle) chemistry. The resulting sequences were then screened and filtered for quality and length. Paired-end sequencing with read lengths of 251 bp was joined together with the fastq-join program (http://code.google.com/p/ea-utils/). Only reads that had quality value (QV) scores of ≥20 for more than 99% of the sequence were extracted for further analysis. The nucleotide sequence dataset was deposited in the Sequence Read Archive of the DNA Data Bank of Japan (DDBJ) under the accession number DRA002295.

Principal component analysis and data mining

Principal component analysis (PCA) was performed using Metagenome@KIN (World Fusion, Tokyo, Japan). Data mining analysis was performed using SPSS Clementine14 software (IBM Japan, Tokyo, Japan). A dividing system using the Classification and Regression Tree (C&RT) approach, which is the most typical method for constructing decision trees, using the Gini coefficient( between obese (or lean) and operational taxonomic unit (OTU) data of the order level was applied. The records were divided into two subsets so that the records within each subset were more homogeneous than in the previous subset.

16S rDNA-based taxonomic analysis and statistical analysis

Analyses of sequence reads were performed using the Ribosomal Database Project (RDP) Multiclassifier tool (http://rdp.cme.msu.edu/classifier/)( and BLAST search using the Metagenome@KIN analysis software (World Fusion) for TechnoSuruga Lab Microbial Identification Database DB-BA9.0 (Technosuruga laboratory, Shizuoka, Japan). Reads showing ≥97% homology were grouped in each taxonomic rank. To evaluate the strength of influence of bacterial species, the LogWorth statistic for partition models was calculated using JMP8 statistical software (SAS Institute, Cary, NC). Differences between different samples were checked for statistical significance (p<0.05) using the Student’s t-tests. The data were analyzed using Statview 5.0 software (SAS).

Results

The baseline characteristics of the 20 subjects are shown in Table 1. Average body mass index (BMI) of the obese group (38.1 ± 3.5 kg/m2) was significantly higher than that of the lean group (16.6 ± 1.0 kg/m2) (p<0.01). Fasting blood sugar and triglyceride levels were also significantly higher in the obese group than in the lean group. Initially, we performed 16S rRNA sequencing of the fecal samples from the obese and lean groups. The average of 20,486 reads per obese sample was significantly higher than the average of 17,358 reads per lean sample (Fig. 1A). In contrast, the Shannon diversity index (H’) was significantly higher in the lean group than in the obese group (Fig. 1B). These results indicate that the fecal microbial structure of lean people is more complex as compared to that of obese people.
Fig. 1

Results of 16S rRNA sequencing of fecal samples from obese (n = 10) and lean people (n = 10). (A) The average read number. The average number of reads per obese person was significantly higher than the average number of reads per lean person. (**p<0.01). (B) Shannon diversity index. The average of the Shannon diversity index was significantly higher in lean people than in obese people (**p<0.01). Data is expressed as mean ± SD (n = 10).

Based on the RDP database, all sequences were classified from the phylum to species. At the phylum level, Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria were dominant in both the obese and lean groups. The phyla Firmicutes and Fusobacteria were significantly more abundant in the obese group than in the lean group (Firmicutes: 42.6 ± 8.5% in obese vs 35.1 ± 5.2% in lean, p = 0.018) (Fig. 2). In particular, the phylum Fusobacterium was detected only in obese people (1.86 ± 4.20% in obese vs 0.00 ± 0.00% in lean, p = 0.002). Previous studies demonstrated an increase of the phylum Bacteroidetes in lean people compared to obese people,( but we could not detect such a difference in our samples (31.2 ± 14.1% in obese vs 32.9 ± 6.4% in lean, p = 0.38). Furthermore, there was no significant difference in the Bacteroidetes/Firmicutes ratio between obese (0.86 ± 0.63) and lean people (0.96 ± 0.27).
Fig. 2

The gut microbial composition of obese and lean people (phylum level). *p<0.05, **p<0.01.

Principal component analysis (PCA) at the phylum level showed different distribution of obese and lean peoples (Fig. 3), suggesting a presence of potential difference between obese and lean microbial structure. Data mining was used to create a decision tree, which is a decision-supporting pathway (Fig. 4). Node 0 (the starting point for tree construction) was divided into Node 1 and Node 2 by the read number of the order Clostridiales with a cutoff value of 5617. Six of the 10 obese people were selectively allocated to Node 2 (Clostridiales read number ˃5,617), and 10 lean people and 4 obese people were allocated to Node 1 (Clostridiales read number ≤5,617). Node 1 was further sub-divided into Nodes 3, 5 and 6. All lean people were allocated to Node 6, which was characterized by a read number for the order Bacteroidales >2,667. These results suggest that at the order level, the microbial community of obese people is characterized by higher Clostridiales and that of lean people is characterized by higher Bacteroidales.
Fig. 3

Principal component analysis (PCA) at the phylum level between obese and lean peoples. PCA based on PC1 (proportion of contribution 59.3%) and of PC2 (proportion of contribution 23.1%) showed different distribution of obese and lean peoples.

Fig. 4

Decision tree constructed using the Classification and Regression Tree (C&RT) approach. The cutoff value to create each node was calculated from the read number of sequence data at the order level, using the Gini coefficient and the C&RT method. Similar steps were repeated to construct the decision tree. Node 0 is the starting point for tree construction, and the terminal node is one that cannot be further divided. The details related to the pathway leading to the terminal node clearly indicate the orders involved and their relative quantities, which contribute to creating the subject groups.

At the genus level, the obtained sequences were assigned to 105 genera, and these were numerically dominated by Bacteroides, Blautia, Bifidobacterium, Eubacterium, Faecalibacterium, Prevotella and Veillonella (Table 2). The genera Alistipes, Anaerococcus, Corpococcus, Fusobacterium and Parvimonas significantly increased in obese people as compared to lean people. In contrast, the genera Bacteroides, Desulfovibrio, Faecalibacterium, Lachnoanaerobaculum and Olsenella significantly increased in lean people compared to obese people.
Table 2

Difference in bacterial composition between obese and lean peoples (Genus level)

GenusObese (%)Lean (%)p value
Increased in obese peoples
Alistipes2.200.500.04
Anaerococcus0.010.000.01
Barnesiella10.247.810.10
Butyricimonas0.010.000.10
Campylobacter0.050.000.08
Coprococcus0.030.280.03
Delftia1.340.740.10
Eubacterium1.860.000.10
Fusobacterium0.010.000.03
Holdemania0.030.000.10
Parvimonas0.010.000.01
Raoultella0.010.000.09
Shigella0.000.000.06
Solobacterium0.541.260.06
Turicibacter2.540.500.09
Increased in lean peoples
Allisonella0.000.020.08
Bacteroides0.080.200.05
 Bifidobacterium0.000.010.11
 Collinsella0.000.000.09
Coprobacillus0.000.000.08
Corynebacterium0.030.340.06
Desulfovibrio0.020.100.05
Enterococcus3.935.940.10
Faecalibacterium0.000.020.04
Finegoldia0.000.100.03
Howardella0.000.000.10
Lachnoanaerobaculum0.000.020.05
Olsenella0.341.150.03
Subdoligranulum0.000.000.04
Sutterella16.9022.500.10
Veillonella0.030.000.09
At the species level, the obtained sequences were assigned to 345 species. Table 3 shows bacteria species that significantly increased in obese people compared to lean people. These included Acidaminococcus intestini, Actinomyces meyeri, Atopobium parvulum, Bacteroides vulgatus, Eubacterium hadrum, Klebsiella pneumoniae and Roseburia faecis. The genus Fusobacterium (F.) including Faecalibacterium (F.) mortiferum, F. nucleatum, and F. varium increased in obese people, but the difference was not significant.
Table 3

Increased bacteria species in obese peoples

SpeciesObese (%)Lean (%)p value
Acidaminococcus intestini1.8510.1020.013
Actinomyces meyeri0.0180.0090.039
Atopobium parvulum0.0060.0010.022
Bacteroides coprophilus0.1370.0020.099
Bacteroides finegoldii0.2820.0440.076
Bacteroides ovatus1.8860.5460.097
Bacteroides vulgatus10.5862.4560.023
Blautia wexlerae5.5893.7980.086
Clostridium butyricum0.0050.0000.172
Clostridium difficile0.0070.0000.130
Clostridium nexile0.1710.0060.081
Coprococcus comes0.6350.2250.065
Eubacterium hadrum2.1570.4380.050
Eubacterium infirmum0.0010.0000.086
Fusobacterium mortiferum1.3760.0020.107
Fusobacterium nucleatum0.0080.0000.093
Fusobacterium varium0.0470.0010.157
Gemella haemolysans0.0080.0010.020
Granulicatella adiacens0.0120.0050.023
Klebsiella pneumoniae subsp.0.0760.0030.042
Lactococcus garvieae0.0000.0040.088
Peptostreptococcus stomatis0.0070.0000.007
Pseudomonas koreensis0.0010.0000.084
Roseburia faecis0.8810.3240.026
Rothia mucilaginosa0.0070.0010.049
Ruminococcus gnavus1.7470.5440.083
Table 4 shows the bacteria species that increased in lean people as compared to obese people. Clostridium ramosum, Clostridium citroniae, Faecalibacterium prausnitzii, Eubacterium desmolans, Eubacterium fissicatena, and Holdemania filiformis significantly increased in lean people compared to obese people (p<0.05). Bilophila wadsworthia tended to increase in lean people, but the difference was not significant.
Table 4

Increased bacteria species in lean peoples

SpeciesObese (%)Lean (%)p value
Clostridium ramosum0.0020.0080.042
Ruminococcus torques0.2300.6850.058
Acetivibrio ethanolgignens0.0000.0140.061
Anaerotruncus colihominis0.0000.0220.089
Bacteroides dorei1.9875.6730.086
Bacteroides stercorirosoris0.0000.0180.089
Bilophila wadsworthia0.0780.2020.051
Christensenella minuta0.0000.0030.070
Clostridium citroniae0.0020.0080.019
Clostridium xylanolyticum0.0460.2080.054
Desulfovibrio piger0.0260.2760.037
Dialister succinatiphilus0.0000.2760.084
Eggerthella lenta0.0160.1020.057
Eubacterium callanderi0.0000.0660.094
Eubacterium coprostanoligenes0.0040.1570.101
Eubacterium desmolans0.0020.1030.029
Eubacterium fissicatena0.0040.0160.038
Eubacterium ruminantium0.0020.1890.061
Faecalibacterium prausnitzii3.9325.9430.050
Flavonifractor plautii0.0690.1520.067
Gordonibacter pamelaeae0.0010.0110.041
Holdemania filiformis0.0000.0030.034
Lactococcus lactis0.0040.0200.088
Lactococcus garvieae0.0000.0040.088
Parabacteroides distasonis0.0010.0070.054
Roseburia hominis0.0060.0990.061
Streptococcus intermedius0.0010.0040.086
Subdoligranulum variabile0.5441.2610.056

Discussion

In this study, we analyzed the fecal microbial community of obese and lean people in the Japanese population. Japan is an island nation and Japanese people are a single ethnic group. In addition, a distinctive food culture developed and has been maintained in this country. Therefore, a unique gut microbial community in the Japanese population is expected. Indeed, Nakayama et al.( recently reported a specific fecal microbial community in Japanese children that consists of more Bifidobacterium and fewer potentially pathogenic bacteria compared to the microbial communities of children in other Asian countries. Previous studies of obesity-associated gut microbiota mainly targeted people living in Western countries, but extensive studies have not been performed on the Japanese population. To understand the influence of certain dietary habits and ethnicity on the gut microbial composition, it would be valuable to characterize the obesity- and lean-associated gut microbial communities of the Japanese population. In this study, we demonstrated that the microbial community of obese Japanese people was characterized by a reduced diversity and an increased abundance of the phyla Firmicutes and Fusobacteria as compared to that of lean people. A reduced diversity and an increased abundance of the phylum Firmicutes in obese people were consistent with previous studies in Western populations.( On the other hand, significance of the phylum Bacteroidetes in the obesity-associated gut microbiota remains to be discussed. Several studies confirmed a decrease of the phylum Bacteroidetes in obese individuals and animal models,( but others did not report any difference between obese and lean subjects or even found the opposite relationship.( In this study, we could not detect a significant difference in the phylum Bacteroidetes. So, we further investigated the microbial structure at the order level using data mining analysis. Data mining was used to create a decision tree, as shown in Fig. 3, which clearly categorized the obese and lean people. Six of the 10 obese people were allocated to Node 2, which is characterized by a higher abundance of the order Clostridiales. In contrast, all of the lean people were allocated to Node 6, which is characterized by a higher abundance of the order Bacteroidales. Thus, the dominance of the order Bacteroidales in lean Japanese people became clear, although there were no definitive findings at the phylum level. Short-chain fatty acids (SCFAs: acetate, propionate and butyrate) are generated through the fermentation of dietary fiber by the gut microbiota.( The bacterial SCFAs provide 10% of the total dietary energy supply in humans,( and fecal SCFA levels increase significantly in obese people compared to lean people.( Both the phyla Firmicutes and Bacteroidetes contribute to SCFA generation. It is known that alteration of the gut microbial composition affects changes in SCFA concentration,( and a higher Firmicutes/Bacteroidetes ratio is associated with obesity via increased generation of SCFAs.( In this study, however, we did not detect a significant difference in the Firmicutes/Bacteroides ratio between obese and lean people, although a higher proportion of the phylum Firmicutes was confirmed in obese people. Similar negative results have been reported previously,( and Murphy et al.( reported that changes in the proportions of the major phyla were unrelated to SCFA concentrations and energy harvest. These results suggest that the linkage between gut microbial composition, SCFA-related energy harvest and obesity may be complex and require further extensive investigations in the future. A novel finding in this study was an increased abundance of the phylum Fusobacteria in obese people. This finding was also confirmed at the genus and species levels. The levels of F. infirmum, F. nucleatum and F. varium were higher in obese people than in lean people, although the difference was not significant. The phylum Fusobacteria induces host inflammatory response and possesses virulence characteristics that promote their adhesiveness to host epithelial cells and their ability to invade into epithelial cells.( Recent studies focused on the association of the phylum Fusobacteria with colorectal cancer,( and F. nucleatum has been shown to potentiate intestinal tumorigenesis by modulating β-catenin signaling.( F. varium has also been reported to be associated with the pathophysiology of ulcerative colitis.( However, the association between the phylum Fusobacteria and obesity has not been described previously. Our results do not imply a causal relationship between the phylum Fusobacteria and obesity, but suggest that the obesity-associated gut microbial community of the Japanese population may have a different composition compared to that of Western people. The exact role of the phylum Fusobacteria in obesity should be investigated in the future. One of the mechanisms by which the intestinal microbiota affects obesity is the induction of systemic low-grade inflammation.( The gut microbiota increases mucosal permeability in obese mice, thereby promoting translocation of bacterial products (e.g., lipopolysaccharide) and stimulating the low-grade inflammation that is characteristic for obesity.( So, bacterial species abundantly present in the lean microbiota with anti-inflammatory properties may have a protective effect on obesity. One of such bacteria species, Faecalibacterium (F.) prausnitzii has strong anti-inflammatory activities via butyrate production and the induction of regulatory T cells,( and has been reported to negatively correlate with inflammatory markers in obese subjects.( In this study, we actually observed a significant increase in the abundance of F. prausnitzii in lean peoples as compared to obese peoples. These results suggest that F. prausnitzii may play a protective role against obesity via its anti-inflammatory actions. In contrast, we observed that the abundance of the phylum Fusobacteria and Bacteroides (B.) increased significantly in obese peoples as compare to lean peoples. The phylum Fusobacteria and B. vulgatus might play a causative role for obesity, since previous studies have reported the proinflammatory properties of these bacteria( and a positive correlation between the abundance of B. vulgatus and BMI.( Thus, it is likely that the balance of inflammatory and anti-inflammatory bacteria may be one of factors affecting the development of obesity. In conclusion, we found that obesity-associated gut microbiota of Japanese people is somewhat different from that of Western people. In Japanese people, a decrease of the phylum Bacteroidetes and a decrease in the Firmicutes/Bacterodetes ratio were not detected. We found an increase of the phylum Fusobacteria in obese people for the first time. The differences between the Japanese population and Western populations could be caused by a variety of factors (e.g., dietary habits, hygiene and genetics).
  37 in total

1.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

2.  Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa.

Authors:  Carlotta De Filippo; Duccio Cavalieri; Monica Di Paola; Matteo Ramazzotti; Jean Baptiste Poullet; Sebastien Massart; Silvia Collini; Giuseppe Pieraccini; Paolo Lionetti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

3.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

4.  An obesity-associated gut microbiome with increased capacity for energy harvest.

Authors:  Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

5.  Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women.

Authors:  A Santacruz; M C Collado; L García-Valdés; M T Segura; J A Martín-Lagos; T Anjos; M Martí-Romero; R M Lopez; J Florido; C Campoy; Y Sanz
Journal:  Br J Nutr       Date:  2010-03-08       Impact factor: 3.718

6.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Stephen S Lim; Theo Vos; Abraham D Flaxman; Goodarz Danaei; Kenji Shibuya; Heather Adair-Rohani; Markus Amann; H Ross Anderson; Kathryn G Andrews; Martin Aryee; Charles Atkinson; Loraine J Bacchus; Adil N Bahalim; Kalpana Balakrishnan; John Balmes; Suzanne Barker-Collo; Amanda Baxter; Michelle L Bell; Jed D Blore; Fiona Blyth; Carissa Bonner; Guilherme Borges; Rupert Bourne; Michel Boussinesq; Michael Brauer; Peter Brooks; Nigel G Bruce; Bert Brunekreef; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Fiona Bull; Richard T Burnett; Tim E Byers; Bianca Calabria; Jonathan Carapetis; Emily Carnahan; Zoe Chafe; Fiona Charlson; Honglei Chen; Jian Shen Chen; Andrew Tai-Ann Cheng; Jennifer Christine Child; Aaron Cohen; K Ellicott Colson; Benjamin C Cowie; Sarah Darby; Susan Darling; Adrian Davis; Louisa Degenhardt; Frank Dentener; Don C Des Jarlais; Karen Devries; Mukesh Dherani; Eric L Ding; E Ray Dorsey; Tim Driscoll; Karen Edmond; Suad Eltahir Ali; Rebecca E Engell; Patricia J Erwin; Saman Fahimi; Gail Falder; Farshad Farzadfar; Alize Ferrari; Mariel M Finucane; Seth Flaxman; Francis Gerry R Fowkes; Greg Freedman; Michael K Freeman; Emmanuela Gakidou; Santu Ghosh; Edward Giovannucci; Gerhard Gmel; Kathryn Graham; Rebecca Grainger; Bridget Grant; David Gunnell; Hialy R Gutierrez; Wayne Hall; Hans W Hoek; Anthony Hogan; H Dean Hosgood; Damian Hoy; Howard Hu; Bryan J Hubbell; Sally J Hutchings; Sydney E Ibeanusi; Gemma L Jacklyn; Rashmi Jasrasaria; Jost B Jonas; Haidong Kan; John A Kanis; Nicholas Kassebaum; Norito Kawakami; Young-Ho Khang; Shahab Khatibzadeh; Jon-Paul Khoo; Cindy Kok; Francine Laden; Ratilal Lalloo; Qing Lan; Tim Lathlean; Janet L Leasher; James Leigh; Yang Li; John Kent Lin; Steven E Lipshultz; Stephanie London; Rafael Lozano; Yuan Lu; Joelle Mak; Reza Malekzadeh; Leslie Mallinger; Wagner Marcenes; Lyn March; Robin Marks; Randall Martin; Paul McGale; John McGrath; Sumi Mehta; George A Mensah; Tony R Merriman; Renata Micha; Catherine Michaud; Vinod Mishra; Khayriyyah Mohd Hanafiah; Ali A Mokdad; Lidia Morawska; Dariush Mozaffarian; Tasha Murphy; Mohsen Naghavi; Bruce Neal; Paul K Nelson; Joan Miquel Nolla; Rosana Norman; Casey Olives; Saad B Omer; Jessica Orchard; Richard Osborne; Bart Ostro; Andrew Page; Kiran D Pandey; Charles D H Parry; Erin Passmore; Jayadeep Patra; Neil Pearce; Pamela M Pelizzari; Max Petzold; Michael R Phillips; Dan Pope; C Arden Pope; John Powles; Mayuree Rao; Homie Razavi; Eva A Rehfuess; Jürgen T Rehm; Beate Ritz; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Jose A Rodriguez-Portales; Isabelle Romieu; Robin Room; Lisa C Rosenfeld; Ananya Roy; Lesley Rushton; Joshua A Salomon; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; Amir Sapkota; Soraya Seedat; Peilin Shi; Kevin Shield; Rupak Shivakoti; Gitanjali M Singh; David A Sleet; Emma Smith; Kirk R Smith; Nicolas J C Stapelberg; Kyle Steenland; Heidi Stöckl; Lars Jacob Stovner; Kurt Straif; Lahn Straney; George D Thurston; Jimmy H Tran; Rita Van Dingenen; Aaron van Donkelaar; J Lennert Veerman; Lakshmi Vijayakumar; Robert Weintraub; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Warwick Williams; Nicholas Wilson; Anthony D Woolf; Paul Yip; Jan M Zielinski; Alan D Lopez; Christopher J L Murray; Majid Ezzati; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

7.  Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers.

Authors:  Jean-Pierre Furet; Ling-Chun Kong; Julien Tap; Christine Poitou; Arnaud Basdevant; Jean-Luc Bouillot; Denis Mariat; Gérard Corthier; Joël Doré; Corneliu Henegar; Salwa Rizkalla; Karine Clément
Journal:  Diabetes       Date:  2010-09-28       Impact factor: 9.461

8.  Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors:  Nicholas J Kassebaum; Amelia Bertozzi-Villa; Megan S Coggeshall; Katya A Shackelford; Caitlyn Steiner; Kyle R Heuton; Diego Gonzalez-Medina; Ryan Barber; Chantal Huynh; Daniel Dicker; Tara Templin; Timothy M Wolock; Ayse Abbasoglu Ozgoren; Foad Abd-Allah; Semaw Ferede Abera; Ibrahim Abubakar; Tom Achoki; Ademola Adelekan; Zanfina Ademi; Arsène Kouablan Adou; José C Adsuar; Emilie E Agardh; Dickens Akena; Deena Alasfoor; Zewdie Aderaw Alemu; Rafael Alfonso-Cristancho; Samia Alhabib; Raghib Ali; Mazin J Al Kahbouri; François Alla; Peter J Allen; Mohammad A AlMazroa; Ubai Alsharif; Elena Alvarez; Nelson Alvis-Guzmán; Adansi A Amankwaa; Azmeraw T Amare; Hassan Amini; Walid Ammar; Carl A T Antonio; Palwasha Anwari; Johan Arnlöv; Valentina S Arsic Arsenijevic; Ali Artaman; Majed Masoud Asad; Rana J Asghar; Reza Assadi; Lydia S Atkins; Alaa Badawi; Kalpana Balakrishnan; Arindam Basu; Sanjay Basu; Justin Beardsley; Neeraj Bedi; Tolesa Bekele; Michelle L Bell; Eduardo Bernabe; Tariku J Beyene; Zulfiqar Bhutta; Aref Bin Abdulhak; Jed D Blore; Berrak Bora Basara; Dipan Bose; Nicholas Breitborde; Rosario Cárdenas; Carlos A Castañeda-Orjuela; Ruben Estanislao Castro; Ferrán Catalá-López; Alanur Cavlin; Jung-Chen Chang; Xuan Che; Costas A Christophi; Sumeet S Chugh; Massimo Cirillo; Samantha M Colquhoun; Leslie Trumbull Cooper; Cyrus Cooper; Iuri da Costa Leite; Lalit Dandona; Rakhi Dandona; Adrian Davis; Anand Dayama; Louisa Degenhardt; Diego De Leo; Borja del Pozo-Cruz; Kebede Deribe; Muluken Dessalegn; Gabrielle A deVeber; Samath D Dharmaratne; Uğur Dilmen; Eric L Ding; Rob E Dorrington; Tim R Driscoll; Sergei Petrovich Ermakov; Alireza Esteghamati; Emerito Jose A Faraon; Farshad Farzadfar; Manuela Mendonca Felicio; Seyed-Mohammad Fereshtehnejad; Graça Maria Ferreira de Lima; Mohammad H Forouzanfar; Elisabeth B França; Lynne Gaffikin; Ketevan Gambashidze; Fortuné Gbètoho Gankpé; Ana C Garcia; Johanna M Geleijnse; Katherine B Gibney; Maurice Giroud; Elizabeth L Glaser; Ketevan Goginashvili; Philimon Gona; Dinorah González-Castell; Atsushi Goto; Hebe N Gouda; Harish Chander Gugnani; Rahul Gupta; Rajeev Gupta; Nima Hafezi-Nejad; Randah Ribhi Hamadeh; Mouhanad Hammami; Graeme J Hankey; Hilda L Harb; Rasmus Havmoeller; Simon I Hay; Ileana B Heredia Pi; Hans W Hoek; H Dean Hosgood; Damian G Hoy; Abdullatif Husseini; Bulat T Idrisov; Kaire Innos; Manami Inoue; Kathryn H Jacobsen; Eiman Jahangir; Sun Ha Jee; Paul N Jensen; Vivekanand Jha; Guohong Jiang; Jost B Jonas; Knud Juel; Edmond Kato Kabagambe; Haidong Kan; Nadim E Karam; André Karch; Corine Kakizi Karema; Anil Kaul; Norito Kawakami; Konstantin Kazanjan; Dhruv S Kazi; Andrew H Kemp; Andre Pascal Kengne; Maia Kereselidze; Yousef Saleh Khader; Shams Eldin Ali Hassan Khalifa; Ejaz Ahmed Khan; Young-Ho Khang; Luke Knibbs; Yoshihiro Kokubo; Soewarta Kosen; Barthelemy Kuate Defo; Chanda Kulkarni; Veena S Kulkarni; G Anil Kumar; Kaushalendra Kumar; Ravi B Kumar; Gene Kwan; Taavi Lai; Ratilal Lalloo; Hilton Lam; Van C Lansingh; Anders Larsson; Jong-Tae Lee; James Leigh; Mall Leinsalu; Ricky Leung; Xiaohong Li; Yichong Li; Yongmei Li; Juan Liang; Xiaofeng Liang; Stephen S Lim; Hsien-Ho Lin; Steven E Lipshultz; Shiwei Liu; Yang Liu; Belinda K Lloyd; Stephanie J London; Paulo A Lotufo; Jixiang Ma; Stefan Ma; Vasco Manuel Pedro Machado; Nana Kwaku Mainoo; Marek Majdan; Christopher Chabila Mapoma; Wagner Marcenes; Melvin Barrientos Marzan; Amanda J Mason-Jones; Man Mohan Mehndiratta; Fabiola Mejia-Rodriguez; Ziad A Memish; Walter Mendoza; Ted R Miller; Edward J Mills; Ali H Mokdad; Glen Liddell Mola; Lorenzo Monasta; Jonathan de la Cruz Monis; Julio Cesar Montañez Hernandez; Ami R Moore; Maziar Moradi-Lakeh; Rintaro Mori; Ulrich O Mueller; Mitsuru Mukaigawara; Aliya Naheed; Kovin S Naidoo; Devina Nand; Vinay Nangia; Denis Nash; Chakib Nejjari; Robert G Nelson; Sudan Prasad Neupane; Charles R Newton; Marie Ng; Mark J Nieuwenhuijsen; Muhammad Imran Nisar; Sandra Nolte; Ole F Norheim; Luke Nyakarahuka; In-Hwan Oh; Takayoshi Ohkubo; Bolajoko O Olusanya; Saad B Omer; John Nelson Opio; Orish Ebere Orisakwe; Jeyaraj D Pandian; Christina Papachristou; Jae-Hyun Park; Angel J Paternina Caicedo; Scott B Patten; Vinod K Paul; Boris Igor Pavlin; Neil Pearce; David M Pereira; Konrad Pesudovs; Max Petzold; Dan Poenaru; Guilherme V Polanczyk; Suzanne Polinder; Dan Pope; Farshad Pourmalek; Dima Qato; D Alex Quistberg; Anwar Rafay; Kazem Rahimi; Vafa Rahimi-Movaghar; Sajjad ur Rahman; Murugesan Raju; Saleem M Rana; Amany Refaat; Luca Ronfani; Nobhojit Roy; Tania Georgina Sánchez Pimienta; Mohammad Ali Sahraian; Joshua A Salomon; Uchechukwu Sampson; Itamar S Santos; Monika Sawhney; Felix Sayinzoga; Ione J C Schneider; Austin Schumacher; David C Schwebel; Soraya Seedat; Sadaf G Sepanlou; Edson E Servan-Mori; Marina Shakh-Nazarova; Sara Sheikhbahaei; Kenji Shibuya; Hwashin Hyun Shin; Ivy Shiue; Inga Dora Sigfusdottir; Donald H Silberberg; Andrea P Silva; Jasvinder A Singh; Vegard Skirbekk; Karen Sliwa; Sergey S Soshnikov; Luciano A Sposato; Chandrashekhar T Sreeramareddy; Konstantinos Stroumpoulis; Lela Sturua; Bryan L Sykes; Karen M Tabb; Roberto Tchio Talongwa; Feng Tan; Carolina Maria Teixeira; Eric Yeboah Tenkorang; Abdullah Sulieman Terkawi; Andrew L Thorne-Lyman; David L Tirschwell; Jeffrey A Towbin; Bach X Tran; Miltiadis Tsilimbaris; Uche S Uchendu; Kingsley N Ukwaja; Eduardo A Undurraga; Selen Begüm Uzun; Andrew J Vallely; Coen H van Gool; Tommi J Vasankari; Monica S Vavilala; N Venketasubramanian; Salvador Villalpando; Francesco S Violante; Vasiliy Victorovich Vlassov; Theo Vos; Stephen Waller; Haidong Wang; Linhong Wang; XiaoRong Wang; Yanping Wang; Scott Weichenthal; Elisabete Weiderpass; Robert G Weintraub; Ronny Westerman; James D Wilkinson; Solomon Meseret Woldeyohannes; John Q Wong; Muluemebet Abera Wordofa; Gelin Xu; Yang C Yang; Yuichiro Yano; Gokalp Kadri Yentur; Paul Yip; Naohiro Yonemoto; Seok-Jun Yoon; Mustafa Z Younis; Chuanhua Yu; Kim Yun Jin; Maysaa El Sayed Zaki; Yong Zhao; Yingfeng Zheng; Maigeng Zhou; Jun Zhu; Xiao Nong Zou; Alan D Lopez; Mohsen Naghavi; Christopher J L Murray; Rafael Lozano
Journal:  Lancet       Date:  2014-05-02       Impact factor: 79.321

9.  Diversity in gut bacterial community of school-age children in Asia.

Authors:  Jiro Nakayama; Koichi Watanabe; Jiahui Jiang; Kazunori Matsuda; Shiou-Huei Chao; Pri Haryono; Orawan La-Ongkham; Martinus-Agus Sarwoko; I Nengah Sujaya; Liang Zhao; Kang-Ting Chen; Yen-Po Chen; Hsueh-Hui Chiu; Tomoko Hidaka; Ning-Xin Huang; Chikako Kiyohara; Takashi Kurakawa; Naoshige Sakamoto; Kenji Sonomoto; Kousuke Tashiro; Hirokazu Tsuji; Ming-Ju Chen; Vichai Leelavatcharamas; Chii-Cherng Liao; Sunee Nitisinprasert; Endang S Rahayu; Fa-Zheng Ren; Ying-Chieh Tsai; Yuan-Kun Lee
Journal:  Sci Rep       Date:  2015-02-23       Impact factor: 4.379

10.  Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus.

Authors:  Deepshika Ramanan; Mei San Tang; Rowann Bowcutt; P'ng Loke; Ken Cadwell
Journal:  Immunity       Date:  2014-07-31       Impact factor: 31.745

View more
  62 in total

1.  The Long-term Impact of Roux-en-Y Gastric Bypass on Colorectal Polyp Formation and Relation to Weight Loss Outcomes.

Authors:  Hisham Hussan; Alyssa Drosdak; Melissa Le Roux; Kishan Patel; Kyle Porter; Steven K Clinton; Brian Focht; Sabrena Noria
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

2.  Obesity and Risk of Small Intestine Bacterial Overgrowth: A Systematic Review and Meta-Analysis.

Authors:  Karn Wijarnpreecha; Monia E Werlang; Kanramon Watthanasuntorn; Panadeekarn Panjawatanan; Wisit Cheungpasitporn; Victoria Gomez; Frank J Lukens; Patompong Ungprasert
Journal:  Dig Dis Sci       Date:  2019-10-11       Impact factor: 3.199

3.  Cecal versus fecal microbiota in Ossabaw swine and implications for obesity.

Authors:  Matthew R Panasevich; Umesh D Wankhade; Sree V Chintapalli; Kartik Shankar; R Scott Rector
Journal:  Physiol Genomics       Date:  2018-03-09       Impact factor: 3.107

4.  Obesity and mental health improvement following nutritional education focusing on gut microbiota composition in Japanese women: a randomised controlled trial.

Authors:  Mayu Uemura; Fumikazu Hayashi; Ken Ishioka; Kunio Ihara; Kazushi Yasuda; Kanako Okazaki; Junichi Omata; Tatsuo Suzutani; Yoshihisa Hirakawa; Chifa Chiang; Atsuko Aoyama; Tetsuya Ohira
Journal:  Eur J Nutr       Date:  2018-12-06       Impact factor: 5.614

5.  Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism.

Authors:  Pedro J Torres; Martyna Siakowska; Beata Banaszewska; Leszek Pawelczyk; Antoni J Duleba; Scott T Kelley; Varykina G Thackray
Journal:  J Clin Endocrinol Metab       Date:  2018-04-01       Impact factor: 5.958

6.  Body fatness over the life course and risk of serrated polyps and conventional adenomas.

Authors:  Chun-Han Lo; Xiaosheng He; Dong Hang; Kana Wu; Shuji Ogino; Andrew T Chan; Edward L Giovannucci; Mingyang Song
Journal:  Int J Cancer       Date:  2020-03-31       Impact factor: 7.396

7.  Synergistic effect of Lactobacillus gasseri and Cudrania tricuspidata on the modulation of body weight and gut microbiota structure in diet-induced obese mice.

Authors:  Ju Kyoung Oh; Mia Beatriz C Amoranto; Nam Su Oh; Sejeong Kim; Ji Young Lee; Ye Na Oh; Yong Kook Shin; Yohan Yoon; Dae-Kyung Kang
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-11       Impact factor: 4.813

Review 8.  Association Between Gut Microbiota and Bone Health: Potential Mechanisms and Prospective.

Authors:  Yuan-Cheng Chen; Jonathan Greenbaum; Hui Shen; Hong-Wen Deng
Journal:  J Clin Endocrinol Metab       Date:  2017-10-01       Impact factor: 5.958

Review 9.  Profile of the gut microbiota of adults with obesity: a systematic review.

Authors:  Louise Crovesy; Daniele Masterson; Eliane Lopes Rosado
Journal:  Eur J Clin Nutr       Date:  2020-03-30       Impact factor: 4.016

10.  Characterization on gut microbiome of PCOS rats and its further design by shifts in high-fat diet and dihydrotestosterone induction in PCOS rats.

Authors:  Yanhua Zheng; Jingwei Yu; Chengjie Liang; Shuna Li; Xiaohui Wen; Yanmei Li
Journal:  Bioprocess Biosyst Eng       Date:  2020-03-10       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.